Ghulam Rehman Mohyuddin, Jenny S Guadamuz, Mustafa S Ascha, Brian C-H Chiu, Pritesh R Patel, Karen Sweiss, Rebecca Rohrer, Douglas Sborov, Gregory S Calip
{"title":"骨髓瘤患者接受唑来膦酸与地诺单抗治疗的比较:一项全国性回顾性队列研究。","authors":"Ghulam Rehman Mohyuddin, Jenny S Guadamuz, Mustafa S Ascha, Brian C-H Chiu, Pritesh R Patel, Karen Sweiss, Rebecca Rohrer, Douglas Sborov, Gregory S Calip","doi":"10.1182/bloodadvances.2024013600","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9228,"journal":{"name":"Blood advances","volume":null,"pages":null},"PeriodicalIF":7.4000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539361/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparison of patients with myeloma receiving zoledronic acid vs denosumab: a nationwide retrospective cohort study.\",\"authors\":\"Ghulam Rehman Mohyuddin, Jenny S Guadamuz, Mustafa S Ascha, Brian C-H Chiu, Pritesh R Patel, Karen Sweiss, Rebecca Rohrer, Douglas Sborov, Gregory S Calip\",\"doi\":\"10.1182/bloodadvances.2024013600\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9228,\"journal\":{\"name\":\"Blood advances\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2024-11-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11539361/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood advances\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1182/bloodadvances.2024013600\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood advances","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/bloodadvances.2024013600","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Blood Advances, a semimonthly medical journal published by the American Society of Hematology, marks the first addition to the Blood family in 70 years. This peer-reviewed, online-only, open-access journal was launched under the leadership of founding editor-in-chief Robert Negrin, MD, from Stanford University Medical Center in Stanford, CA, with its inaugural issue released on November 29, 2016.
Blood Advances serves as an international platform for original articles detailing basic laboratory, translational, and clinical investigations in hematology. The journal comprehensively covers all aspects of hematology, including disorders of leukocytes (both benign and malignant), erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. Each article undergoes a rigorous peer-review process, with selection based on the originality of the findings, the high quality of the work presented, and the clarity of the presentation.